Topic: molecular diagnostics
GNA Biosolutions raised $13.5 million to support its point-of-care diagnostic platform designed to quickly examine different genomic samples.
LabCorp tapped Mission Bio to provide single-cell DNA analysis in a collaboration with its Covance drug development arm.
Tuesday, April 9, 2019
Join this webinar to discover the advantages of using Signatera™ (RUO), a novel assay custom-designed for each patient that detects circulating tumor DNA (ctDNA) with high sensitivity and specificity to monitor molecular residual disease, early recurrence, and treatment response across solid tumors.
Caris Life Sciences has launched a new whole transcriptome sequencing test for tumor RNA analysis.
The FDA approved a molecular diagnostic test that can match blood donors using patient DNA.
Qiagen announced plans for global launches of tuberculosis and molecular diagnostic tests developed with two separate companies.
The $4.4 million award sets Talis up to work on a molecular diagnostic capable of detecting the bacteria in patient samples within 20 minutes.
ArcherDX will use the money to grow its commercial operations while building out the companion diagnostic program that landed it a deal with Celgene.
The companies are part of a star-studded commission that is working on a road map for improving outcomes in rare diseases.
Gottlieb thinks revisions are needed to give the FDA authorities that are a better fit for modern diagnostics than the current 510(k) pathway.